FIBROMYALGIA: A COMPLEX PAIN PROBLEM
Article Sidebar
Main Article Content
Abstract
ABSTRACTFibromyalgia is derived from Greek words, “fibro” meaning fibrous tissue, “myo” meaning muscle and “algos” meaning pain. It is characterized by widespread constant musculoskeletal pain and allodynia (heightened painful response to pressure on various body parts). Other associated symptoms include extreme fatigue, sleep disturbances, joint stiffness, bladder and bowel problems, swallowingproblems, sensory and cognitive abnormalities. The article gives a review of the latest literature in the management of fibromyalgia.
Article Details
Work published in KMUJ is licensed under a
Creative Commons Attribution 4.0 License
Authors are permitted and encouraged to post their work online
(e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
References
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldberg DL, et al. The American College of Rheumatology 1990 Criteria for the Classification ofCriteria Committee. Arthritis Rheum 1990; 33 (2): 160-72.
Wolfe F. Fibromyalgia: the clinical syndrome.
Rheum Dis Clin North Am 1989; 15 (1): 1-18.
Clauw DJ, Schmidt M, Radulovic D, Singer A, Katz P, Bresette J. The relationship between
fibromyalgia and interstitial cystitis. J Psychiatr Re 1997; 31 (1): 125-31.
Wallace DJ, Hallegua DS. Fibromyalgia: the gastrointestinal link. Curr Pain Headache Rep 2002; 8 (5): 364-8.
Simms RW, Goldenberg DL. Symptoms mimicking neurologic disorders in fibromyalgia
syndrome. J Rheumatol 1988; 15 (8): 1271-3.
Glass JM. Cognitive dysfunction in fibromyalgia
and chronic fatigue syndrome: new trends and future directions. Curr Rheumatol Rep 2006; 8 (6): 425-9.
Weir PT, Harlan GA, Nkoy FL, Jones SS, Hegmann KT, Gren LH, et al. The incidence of fibromyalgia and its associated
comorbidities: a population based retrospective cohort study based on International Classification of Diseases, 9th Revision codes. J Clin Rheumatol 2006; 12(3): 124-8.
Bartels EM. Dreyer L, Jacobsen S, Jespersen
A, Blidal H, Danneskiold-Samsøe. Fibromyalgia, diagnosis and prevalence. Are gender differences explainable? Ugeskr Laeger 2009; 171 (49): 3588-92.
Wolfe F, Clauw DJ, Fitzcharles MA, Goldberg DL, Katz RS, Russell AS, et al. The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia
and Measurement of Symptom Severity. Arthritis Care & Research, 2010; 62 (5): 600.
Wolfe F. Fibromyalgia wars. J Rheumatol 2009; 36 (4): 671-8.
Goldenberg DL. Fibromyalgia why such controversy? Ann Rheum Dis 1995; 54 (1): 3-5.
Ngian GS, Guymer EK, Littlejohn GO. The use of opioids in fibromyalgia. Int J Rheum Dis 2011; 14 (1): 6-11.
Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, et al. Family study of fibromyalgia. Arthritis Rheum 2004; 50 (3): 944-52.
Schweinhardt P, Sauro KM, Bushnell MC. Fibromyalgia: A disorder of the brain? Neuroscientist 2008; 14 (5): 415-21.
Häuser W, Kosseva M, Üceyler N, Klose P, Sommer C. Emotional, physical, and sexual abuse in fibromyalgia syndrome: A systematic review with meta-analysis. Arthritis Care & Research 2011; 63 (6): 808-20.
Wood PB. Stress and dopamine: implications
for the pathophysiology of chronic widespread pain. Medical Hypothesis 2004; 62 (3): 420-4.
Holman AJ, Myers RR. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant
medications. Arthritis Rheum 2005; 52 (8): 2495-505.
Goldenberg DL. Fibromyalgia syndrome a decade later: What have we learned? Arch Intern Med 1999; 159 (8): 777-85.
Carville SF, Arendt-Nielsen S, Bliddal H et al. EULAR evidence-based recommendations
for the management of fibromyalgia syndrome. Ann Rheum Dis 2008; 67 (4): 536-41.
Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, et al. Pregabalin for the treatment of fibromyalgia
syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005; 52: 1264-73.
Mease PJ, Russell IJ, Arnold LM, Florian H, Young JP, Martin SA, et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol. 2008; 35: 502-14.
Arnold LM, Russell IJ, Diri EW, Duan WR, Young JP, Sharma U, et al. A 14-week, randomized,
double-blinded, placebo-controlled
monotherapy trial of pregabalin in patients with fibromyalgia. J Pain 2008; 9: 792-805.
Crofford LJ, Mease PJ, Simpson SL. Fibromyalgia relapse evaluation and efficacy
for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain 2008; 136: 419-31.
Arnold LM, Goldenberg DL, Stanford SB, Lalonde JK, Sandhu HS, Keck PE, et al. Gabapentin
in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled,
multicenter trial. Arthritis Rheum 2007; 56: 1336-44.
Häuser W, Bernardy K, Uçeyler N, Sommer C. Treatment of fibromyalgia syndrome with antidepressants: a meta-
analysis. J Am Med Assoc 2009; 301 (2): 198-209.
Lesley M, Arnold MD. Strategies for Managing Fibromyalgia. Am J Med 2009; 122: S31-S43.
Adelman LC, Adelman JU, Von Seggern R, Mannix LK. Venlafaxine extended release (XR) for the prophylaxis of migraine and tension type headache: a retrospective study in a clinical setting. Headache 2000; 40: 572-580.
Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. J Am Med Assoc 2004; 292: 2388-95.
Arnold LM, Pritchett YL, D’Souza DN, Kajdasz DK, Iyengar S, Wernicke JF. Duloxetine for the treatment of fibromyalgia
in women: pooled results from two randomized. Placebo-controlled clinical trials. J Womens Health (Larchmt) 2007; 16(8): 1145-56.
Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double blind, placebo-controlled, fixed-dose trial. Pain 2008;136: 432-44.
Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. [published correction appears in Clin Ther 2009;31:446] Clin Ther 2008; 30: 1988-2004.
Sorensen J, Bengtsson A, Backman E, Henriksson
KG, Bengtsson M. Pain analysis in patients with fibromyalgia. Effects of intravenous
morphine, lidocaine and ketamine. Scand J Rheumatol 1995; 24(6): 360-5.
Kemple KL, Smith G, Wong-Ngan J. Opioid therapy in fibromyalgia: A four year prospective evaluation of therapy selection, efficacy, and predictors of outcome
[abstract]. Arthritis Rheum 2003; (suppl): 48(S88).
Wolfe F, Anderson J, Harkness D, et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 1997; 40: 1560-70.
Biasi G, Manca S, Manganelli S, Marcolongo R. Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharmacol Res 1998; 18: 13-9.
Bennett RM, Kamin M, Karim R, Rosenthal N. Tramadol and acetaminophen combination
tablets in the treatment of fibromyalgia
pain: A double-blind, randomized, placebo-controlled study. Am J Med 2003; 114: 537-45.
Skraber RQ, Galimova L, Ethans K, Perry D. Nabilone for the treatment of fibromyalgia.
J Pain 2008; 9(2): 164-73.38.
Holman AJ, Myers RR. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant
medications. Arthritis Rheum 2005; 52: 2495-2505.
See S, Ginzburg R. Choosing a skeletal muscle relaxant. Am Fam Physician 2008; 78(3): 365-70.
Färber L, Stratz T, Bruckle W, et al, for the German Fibromyalgia Study Group. Efficacy and tolerability of tropisetron in primary fibromyalgia — a highly selective and competitive 5-HT3 receptor antagonist.
Scand J Rheumatol Suppl 2000; 113: 49-54.
Yunus MB, Masi AT, Aldag JC. Short term effects of ibuprofen in primary fibromyalgia
syndrome: a double blind, placebo controlled trial. J Rheumatol 1989; 16: 527-32.
Clark S, Tindall E, Bennett RM. A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis. J Rheumatol 1985; 12: 980-3.
Clark SR, Bennett RM. Supplemental dextromethorphan
in the treatment of fibromyalgia:
a double blind, placebo controlled study of efficacy and side effects [abstract]. Arthritis Rheum. 2000; 43 (suppl): S333.
Vlaeyen JW, Teeken-Gruben NJ, Goossens ME, Rutten-van Mölken MP, Pelt RA, van Eek H, et al. Cognitive educational treatment
of fibromyalgia: a randomized clinical trial. I. Clinical effects. J Rheumatol 1996; 23: 1237-45.
Busch A, Schachter CL, Peloso PM, Bombardier
C. Busch, Angela. ed. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev 2002; (3): CD003786.
Mannerkorpi, K., Nyberg, B., Ahlmén M., & Ekdahl C. Pool exercise combined with an education program for patients with fibromyalgia syndrome: a prospective, randomized
study. Journal of Rheumatology 2002; 27: 2473-81.
Wang C, Schmid CH, Rones R, Kalish R, Yinh J, Goldenberg DL et al. A randomized trial of tai chi for fibromyalgia. N Engl J Med 2010; 363 (8): 743-54.
Oliver K, Cronan TA, Walen HR, Tomita M. Effects of social support and education on health care costs for patients with fibromyalgia.
J Rheumatol 2001; 28: 2711-9.
Mayhew E, Ernst E. Acupuncture for fibromyalgia — a systematic review of randomized clinical trials. Rheumatology (Oxford). 2007; 46: 801-804.
Astin JA, Berman BM, Bausell B, Lee WL, Hochberg M, Forys KL. The efficacy of mindfulness meditation plus Qigong movement therapy in the treatment of fibromyalgia: A randomized controlled trial. J Rheumatol 2003; 30: 2257-62.